Elsevier

Brain Research

Volume 1581, 18 September 2014, Pages 117-128
Brain Research

Research Report
YAC128 Huntington׳s disease transgenic mice show enhanced short-term hippocampal synaptic plasticity early in the course of the disease

https://doi.org/10.1016/j.brainres.2014.06.011Get rights and content

Highlights

  • Early symptomatic YAC128 HD mice show reduced dentate gyrus paired-pulse depression.

  • Early symptomatic YAC128 HD mice maintain enhanced post-tetanic potentiation with age.

  • Dentate gyrus short-term plasticity is altered in early symptomatic YAC128 HD mice.

  • Dentate gyrus long-term plasticity is unaffected in early symptomatic YAC128 HD mice.

Abstract

Huntington׳s disease (HD) is a progressive and fatal neurodegenerative disorder caused by a polyglutamine expansion in the gene encoding the protein huntingtin. The disease progresses over decades, but often patients develop cognitive impairments that precede the onset of the classical motor symptoms. Similar to the disease progression in humans, the yeast artificial chromosome (YAC) 128 HD mouse model also exhibits cognitive dysfunction that precedes the onset of the neuropathological and motor impairments characteristic of HD. Thus, the purpose of this study was to evaluate whether short- and long-term synaptic plasticity in the hippocampus, two related biological models of learning and memory processes, were altered in YAC128 mice in early stages of disease progression. We show that the YAC128 hippocampal dentate gyrus (DG) displays marked reductions in paired-pulse depression both at 3 and 6 months of age. In addition, significantly enhanced post-tetanic and short-term potentiation are apparent in YAC128 mice after high-frequency stimulation at this time. Early and late forms of long-term plasticity were not altered at this stage. Together these findings indicate that there may be elevated neurotransmitter release in response to synaptic stimulation in YAC128 mice during the initial phase of disease progression. These abnormalities in short-term plasticity detected at this stage in YAC128 HD transgenic mice indicate that aberrant information processing at the level of the synapses may contribute, at least in part, to the early onset of cognitive deficits that are characteristic of this devastating neurodegenerative disorder.

Introduction

Huntington׳s disease (HD) is an autosomal dominant neurodegenerative disorder that affects approximately 1 in 20,000 people worldwide (Harper, 1996). HD typically has an adult onset and is characterized by a variety of psychiatric, cognitive, and motor symptoms, culminating in death within 12–15 years of the time of onset (Folstein, 1989). The earliest symptoms of HD include mood swings, depression, irritability, and impaired learning and memory. As the disease progresses, concentration on intellectual tasks becomes increasingly difficult, and eventually patients may develop severe dementia (Harper, 1996). Interestingly, the cognitive deficits usually appear years before the onset of the classical motor symptoms. Furthermore, post-mortem studies suggest that the first cognitive symptoms appear in the absence of significant neurodegeneration and cell death (Vonsattel et al., 1985). Thus, it may be that impairments in cognition are caused by changes in neuronal communication preceding neuronal cell loss in non-striatal brain regions.

Changes in synaptic efficacy in the hippocampus are thought to underlie cognitive processes such as learning and memory (Bliss and Collingridge, 1993, Bruel-Jungerman et al., 2007a, Bruel-Jungerman et al., 2007b, Citri and Malenka, 2008). Various studies have reported impairments in long-term potentiation (LTP) in the Cornu ammonis 1 (CA1) sub-region of the hippocampus of knock-in (Lynch et al., 2007, Simmons et al., 2009) and R6/2 transgenic (Murphy et al., 2000) HD mice, which express exon 1 of the human HD gene with approximately 150 CAG repeats (Mangiarini et al., 1996). Conversely, enhanced LTP has also been observed in the CA1 of yeast artificial chromosome (YAC) 72 HD mice (Usdin et al., 1999), which express the full-length human HD gene with 72 CAG repeats (Hodgson et al., 1999). This alteration was detected at 6 months of age, a time-point prior to the development of the behavioral phenotype. However, by 10 months, LTP could no longer be induced in these full-length HD transgenic mice, a deficit that appears to be associated with an increase in the resting levels of Ca2+ within YAC neurons (Usdin et al., 1999).

YAC128 HD transgenic mice express the full-length human HD gene with 128 CAG repeats (Slow et al., 2003) and faithfully recapitulate many features of the human condition (Gil-Mohapel, 2012). These mice develop behavioral abnormalities that follow a biphasic pattern with an initial phase of hyperactivity followed by the onset of motor deficits, which can be detected as early as 2 months and clearly by 4 months of age and finally by hypokinesis (Graham et al., 2006a, Graham et al., 2006b, Slow et al., 2003, Van Raamsdonk et al., 2007, Van Raamsdonk et al., 2005b, Van Raamsdonk et al., 2005c). Furthermore, YAC128 mice also develop mild cognitive deficits, which precede the onset of motor abnormalities and can be detected as early as 2 months of age and progressively deteriorate with the course of the disease (Van Raamsdonk et al., 2005c). These mice also develop a depressive-like behavior at the early stage of 3 months of age (Pouladi et al., 2009). At the neuropathological level, significant atrophy of the striatum, globus pallidus and cortex can be detected by stereological methods at 9 months of age (Slow et al., 2003, Van Raamsdonk et al., 2005a). However, subtle early striatal neuropathological changes can be observed with more sophisticated techniques (i.e., magnetic resonance imaging) as early as 3 months of age (Carroll et al., 2011). We have recently reported deficits in adult hippocampal neurogenesis, a form of structural plasticity, in this full-length HD transgenic mouse model (Simpson et al., 2011). Importantly, deficits in hippocampal neurogenesis can be detected as early as 3 months of age (Simpson et al., 2011), before the onset of overt motor symptoms and the appearance of striatal neuropathological deficits (Slow et al., 2003). As alterations in both structural and functional hippocampal plasticity might underlie some of the early cognitive deficits characteristic of this HD transgenic mouse model (Van Raamsdonk et al., 2005c), in the present study we examined whether functional (i.e., synaptic) short- and long-term plasticity were also altered during the early stages of the disease in YAC128 HD mice.

Section snippets

Normal basal synaptic transmission but reduced paired-pulse depression in the dentate gyrus of YAC128 mice during the early stages of disease progression

We evaluated synaptic transmission in 3- and 6-month old YAC128 animals by constructing a field excitatory post-synaptic potential (fEPSP) Input/Output (I/O) curve in response to a series of ascending stimulus intensities. For both age groups, the slope of the fEPSP significantly increased with increasing stimulation [repeated measures analysis of variance (ANOVA); F(1,806)=1805.0, P=0.0000]. There were no significant main effects for either genotype (F(1,806)=0.0006, P=0.98), or age (F(1,806)

Discussion

To date, much of the research on the mechanisms underlying HD has focused on striatal degeneration, which primarily accounts for the motor impairments characteristic of this disorder. While other brain regions have received less attention, HD patients also show cell loss in non-striatal brain regions, including the hippocampus (Rosas et al., 2003, Spargo et al., 1993, Vonsattel and DiFiglia, 1998). Hippocampal dysfunction in the absence of cell loss has also been repeatedly shown in various HD

Conclusions

We demonstrate that YAC128 transgenic mice show enhanced short-term plasticity in the hippocampal DG early on during the course of the disease. Our results indicate that in the YAC128 DG, presynaptic terminals sustain increased neurotransmitter release and enhanced postsynaptic receptor sensitivity with repeated HFS. We speculate that this mechanism, while perhaps beneficial during the initial stages of the disease, might eventually render these neurons susceptible to excitotoxicity and

Animals

YAC128 transgenic mice (Slow et al., 2003) and their WT littermates were used for these experiments (YAC128=19; WT=15). The YAC128 transgenic colony was maintained on the FVB/N background strain (Charles River, Wilmington, MA, USA). Animals were sexed, weaned, and ear-punched at post-natal day 24 and group-housed with minimal enrichment (free access to tubes or nestlets) and ad libitum access to food and water. The colony was maintained in a normal 12 h light/dark cycle and ambient temperature

Acknowledgments

The authors would like to thank Dr. Michael Hayden (Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada) for donating the YAC128 breeding pairs used to initiate the colony at the University of Victoria. The authors would also like to acknowledge Jennifer Graham for breeding and maintaining the YAC128 mouse colony. J.M.S. was supported by scholarships from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Michael

References (77)

  • R.K. Graham et al.

    Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models

    Neurobiol. Dis.

    (2006)
  • M.Y. Heng et al.

    Rodent genetic models of Huntington disease

    Neurobiol. Dis.

    (2008)
  • J.G. Hodgson et al.

    A YAC mouse model for Huntington׳s disease with full-length mutant Huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration

    Neuron

    (1999)
  • K. Huang et al.

    Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease

    Neurobiol. Dis.

    (2010)
  • S.J. Huber et al.

    Memory impairment associated with progression of Huntington׳s disease

    Cortex

    (1987)
  • I. Labuschagne et al.

    Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington׳s disease

    Psychiatry Res.

    (2013)
  • L. Mangiarini et al.

    Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

    Cell

    (1996)
  • J. Nithianantharajah et al.

    Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington׳s disease transgenic mice

    Neurobiol. Dis.

    (2008)
  • Q. Peng et al.

    The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington׳s disease mouse model

    Exp. Neurol.

    (2008)
  • J.M. Simpson et al.

    Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease

    Neurobiol. Dis.

    (2011)
  • J.S. Snyder et al.

    A role for adult neurogenesis in spatial long-term memory

    Neuroscience

    (2005)
  • J.M. Van Raamsdonk et al.

    Testicular degeneration in Huntington disease

    Neurobiol. Dis.

    (2007)
  • M.M. Zeron et al.

    Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington׳s disease

    Mol. Cell. Neurosci.

    (2004)
  • M.M. Zeron et al.

    Increased Sensitivity to N-methyl-d-aspartate receptor-mediated exitotoxicity in a mouse model of Huntington׳s Disease

    Neuron

    (2002)
  • M.S. Albert et al.

    Development of remote memory loss in patients with Huntington׳s disease

    J. Clin. Neuropsychol.

    (1981)
  • T. Arzberger et al.

    Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington׳s disease—an in situ hybridization study

    J. Neuropathol. Exp. Neurol.

    (1997)
  • P.F. Behrens et al.

    Impaired glutamate transport and glutamate–glutamine cycling: downstream effects of the Huntington mutation

    Brain

    (2002)
  • C. Beste et al.

    Evidence for divergent effects of neurodegeneration in Huntington׳s disease on attentional selection and neural plasticity: implications for excitotoxicity

    Brain Struct. Funct.

    (2014)
  • T.V.P. Bliss et al.

    A synaptic model of memory: long-term potentiation in the hippocampus

    Nature

    (1993)
  • E. Bruel-Jungerman et al.

    Brain plasticity mechanisms and memory: a party of four

    Neurosci

    (2007)
  • E. Bruel-Jungerman et al.

    Adult hippocampal neurogenesis, synaptic plasticity and memory: facts and hypotheses

    Rev. Neurosci.

    (2007)
  • E.D. Caine et al.

    An outline for the analysis of dementia

    Neurology

    (1977)
  • C.A. Chapman et al.

    Effects of GABA(A) inhibition on the expression of long-term potentiation in CA1 pyramidal cells are dependent on tetanization parameters

    Hippocampus

    (1998)
  • A. Citri et al.

    Synaptic plasticity: multiple forms, functions, and mechanisms

    Neuropsychopharmacology

    (2008)
  • K.E. Davis et al.

    Increased hippocampal excitability in the 3xTgAD mouse model for Alzheimer׳s disease in vivo

    PLoS One

    (2014)
  • B.D. Eadie et al.

    NMDA receptor hypofunction in the dentate gyrus and impaired context discrimination in adult Fmr1 knockout mice

    Hippocampus

    (2012)
  • A.M. Estrada-Sánchez et al.

    Glycolysis inhibition decreases the levels of glutamate transporters and enhances glutamate neurotoxicity in the R6/2 Huntington׳s disease mice

    Neurochem. Res.

    (2010)
  • H.E. Gibson et al.

    A similar impairment in CA3 mossy fibre LTP in the R6/2 mouse model of Huntington׳s disease and in the complexin II knockout mouse

    Eur. J. Neurosci.

    (2005)
  • Cited by (19)

    • The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases

      2022, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      This, in addition to increases in striatal glutamate receptor expression and binding (Benn et al., 2007), and suggests that striatal cell death is mediated by excitotoxic mechanisms (Gil and Rego, 2008; Joshi et al., 2009; Milnerwood and Raymond, 2007). YAC128 mice also show a reduction in adult hippocampal neurogenesis (Gil-Mohapel et al., 2011; Simpson et al., 2011) and short-term plasticity, despite normal long-term plasticity (Ghilan et al., 2014), which may contribute, at least in part, to the cognitive deficits observed in these mice. With regards to aggregation of mutant HTT and inclusion formation, YAC128 show NIIs in late end-stage animals only (e.g. at approximately 18 months of age) (Slow et al., 2003).

    • Depression in neurodegenerative diseases: Common mechanisms and current treatment options

      2019, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      Within this scenario, pharmacological interventions able to restore BDNF levels and hippocampal neurogenesis can also rescue depressive-like phenotypes in transgenic models of HD (Ben M’Barek et al., 2013; Grote et al., 2005; Peng et al., 2008). Moreover, BDNF also plays a role in synaptic structure and function (Bramham and Messaoudi, 2005), and several studies have shown that hippocampal synaptic dysfunction can occur during the early stages of disease progression in various transgenic models of HD (Ghilan et al., 2014; Milnerwood et al., 2010; Murphy et al., 2000; Usdin et al., 1999), while also being a pathophysiological hallmark of MDD (Duman et al., 2016; Duman and Aghajanian, 2012). Thus, it is likely that modulation of hippocampal synaptic plasticity can mediate, at least in part, the beneficial effects (i.e., reduction of depressive-like symptoms) of therapeutic interventions that increase BDNF levels in HD transgenic mouse models (Lu et al., 2013; Simmons et al., 2009).

    • Spatial memory in Huntington's disease: A comparative review of human and animal data

      2019, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      The YAC128 mouse model demonstrates impaired learning and memory starting at 8 months of age and progressively worsening (Van Raamsdonk et al., 2005), which has been attributed to reduced hippocampal neurogenesis in the dentate gyrus, leading to a reduced number of young neurons in the hippocampus (Simpson et al., 2011). Changes in long-term potentiation, however, are not observed in the early pre-symptomatic (6-months) hippocampus (Ghilan et al., 2014). Several molecular mechanisms have been proposed to describe the cognitive decline observed in transgenic mouse models and HD patients.

    • Revisiting the flip side: Long-term depression of synaptic efficacy in the hippocampus

      2017, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      Thus, in the R6 transgenic lines (which express exon 1 of the human HD gene), LTD was shown to be enhanced in the CA1 of 1- and 4-month old R6/2 mice (with approximately 145 CAG repeats), as well as in 6-month old transgenic R6/1 mice (with approximately 115 CAG repeats) (Milnerwood et al., 2006; Murphy et al., 2000). In contrast, we have recently shown no alterations in the capacity to induce DG LTD in early-symptomatic (3- and 6-month old) yeast artificial chromosome (YAC) 128 mice (which express the full-length human HD gene with 128 CAG repeats) (Ghilan et al., 2014). Again, differences between the various transgenic models of HD used and the hippocampal sub-regions analyzed may account, at least in part, for the discrepancies among these findings.

    View all citing articles on Scopus
    View full text